Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.

Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

Those with prostate cancer that returns after surgery or radiation—and typically face a high risk of the disease spreading and death—could benefit from a new drug combination. A Cedars-Sinai Medical ...

Camcevi ETM, a long-acting injectable, is FDA-approved for advanced prostate cancer, showing 97.9% efficacy in testosterone suppression in a phase 3 study. Common side effects include hot flushing and ...

Add Yahoo as a preferred source to see more of our stories on Google. The once-daily pill, with its brand name Talzenna and produced by Pfizer, offers a crucial at-home treatment option after ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...